跳至主要内容
临床试验/NCT04073888
NCT04073888终止不适用

Study of the Spermatic Characteristics of Patients With Fabry Disease

University Hospital, Bordeaux1 个研究点 分布在 1 个国家目标入组 22 人开始时间: 2009年2月20日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
发起方
入组人数
22
试验地点
1
主要终点
volume (ml) of sperm

研究概览

简要总结

The objective of this project is to estimate the prevalence of spermatic abnormalities in patients with Fabry disease.The main objective of this project is to estimate the prevalence of spermatic abnormalities in patients with Fabry disease.

详细描述

Fabry disease is a lysosomal storage burden of X-linked genetic transmission due to alpha-galactosidase deficiency. This enzyme deficiency causes deposits of globotriaosylceramide in virtually all cell types of the body. The majority of hemizygous men develop a severe multisystemic disease dominated by renal failure, neurological and cardiac involvement. There is a specific treatment based on enzyme replacement therapy.

The incidence of Fabry disease is estimated between 1/60000 and 1/3500 in the general population.

Infertility in Fabry disease is poorly documented. Only a few cases have been reported, from alteration of spermogram to azoospermia. The identification of deposits suggestive of Gb3 in light microscopy and electron microscopy at the level of the genital tract argues in favor of the attack of this device. The low prevalence of Fabry disease requires a cross-sectional multicenter study to determine the frequency of alterations in sperm characteristics, their impact on fertility, and the possible effect of substitution therapy, in order to establish appropriate measures. adequate preventive measures.

The objective of this project is to estimate the prevalence of spermatic abnormalities in patients with Fabry disease.The main objective of this project is to estimate the prevalence of spermatic abnormalities in patients with Fabry disease.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • male patients with Fabry disease regardless of the clinical form of the disease; treated with enzyme replacement therapy or not (from the initial diagnosis). The definite diagnosis of Fabry disease will be established on the deficit of the activity of alpha galactosidase A (<12%). A molecular genetic study is desirable but not mandatory,
  • patients aged 18 to 65,
  • giving their free and informed consent to participate, after information on the research.

排除标准

  • persons placed under the protection of justice,
  • unaffiliated or non-beneficiary subject of a social security scheme.

研究组 & 干预措施

Single arm

Other

Men with Fabry Disease

干预措施: Semen collection (Procedure)

结局指标

主要结局

volume (ml) of sperm

时间窗: At Day 1

Spermogram characteristics

pH of sperm

时间窗: At Day 1

Spermogram characteristics

Count (million / ml) of spermatozoids

时间窗: At Day 1

Spermogram characteristics

Mobility (%) and mobility type of spermatozoa according to WHO classification of spermatozoids

时间窗: At Day 1

Spermogram characteristics

Total number of spermatozoa in one ejaculate

时间窗: At Day 1

Spermogram characteristics

Total number of progressive motile spermatozoa

时间窗: At Day 1

Spermogram characteristics

Existence of leukospermia yes/no

时间窗: At Day 1

Spermogram characteristics

% of typical forms of spermatozoids

时间窗: At Day 1

Characteristics of spermocytogram

Multiple Anomalies Index (MAI) of spermatozoids

时间窗: At Day 1

Characteristics of spermocytogram

次要结局

未报告次要终点

研究者

发起方
University Hospital, Bordeaux
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验